相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Two decades of thyroglobulin type-1 domain research
Marko Mihelic et al.
BIOLOGICAL CHEMISTRY (2007)
The role of cystatins in cells of the immune system
Natasa Kopitar-Jerala
FEBS LETTERS (2006)
Mouse stefins A1 and A2 (Stfa1 and Stfa2) differentiate between papain-like endo- and exopeptidases
Marko Mihelic et al.
FEBS LETTERS (2006)
Endosomal proteases in antigen presentation
HA Chapman
CURRENT OPINION IN IMMUNOLOGY (2006)
The lysosomal cysteine proteases in MHC class II antigen presentation
LC Hsing et al.
IMMUNOLOGICAL REVIEWS (2005)
In vivo control of endosomal architecture by class II-associated invariant chain and cathepsin S
M Boes et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
Inhibitory properties of cystatin F and its localization in U937 promonocyte cells
T Langerholc et al.
FEBS JOURNAL (2005)
Cathepsin L is crucial for a Th1-type immune response during Leishmania major infection
K Onishi et al.
MICROBES AND INFECTION (2004)
Class II MHC peptide loading by the professionals
P Bryant et al.
CURRENT OPINION IN IMMUNOLOGY (2004)
Cathepsin V, a novel and potent elastolytic activity expressed in activated macrophages
Y Yasuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Cysteine protease cathepsin F is expressed in human atherosclerotic lesions, is secreted by cultured macrophages, and modifies low density lipoprotein particles in vitro
K Öörni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibitory p41 isoform of invariant chain and its potential target enzymes cathepsins L and H in distinct populations of macrophages in human lymph nodes
V Zavasnik-Bergant et al.
IMMUNOLOGY (2004)
The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation
D El-Sukkari et al.
JOURNAL OF IMMUNOLOGY (2003)
Cathepsin V is involved in the degradation of invariant chain in human thymus and is overexpressed in myasthenia gravis
E Tolosa et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Lysosomal cysteine proteases (cathepsins): promising drug targets
D Turk et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2003)
Invariant chain controls the activity of extracellular cathepsin L
E Fiebiger et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
The crystal structure of human cathepsin F and its implications for the development of novel immunomodulators
JR Somoza et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
A role for cathepsin L and cathepsin S in peptide generation for MHC class II presentation
CS Hsieh et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulating cysteine protease activity: Essential role of protease inhibitors as guardians and regulators
B Turk et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Structure of a Cys25 -> Ser mutant of human cathepsin S
JP Turkenburg et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2002)
Structure of human dipeptidyl peptidase I (cathepsin C): exclusion domain added to an endopeptidase framework creates the machine for activation of granular serine proteases
D Turk et al.
EMBO JOURNAL (2001)
The p41 isoform of invariant chain is a chaperone for cathepsin L
AM Lennon-Duménil et al.
EMBO JOURNAL (2001)
Crystal structure of human cathepsin V
JR Somoza et al.
BIOCHEMISTRY (2000)
Role for cathepsin F in invariant chain processing and major histocompatibility complex class II peptide loading by macrophages
GP Shi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Control of antigen presentation by a single protease cleavage site
AN Antoniou et al.
IMMUNITY (2000)
Cathepsins and compartmentalization in antigen presentation
RJ Riese et al.
CURRENT OPINION IN IMMUNOLOGY (2000)
Proteolysis in MHC class II antigen presentation: Who's in charge?
JA Villadangos et al.
IMMUNITY (2000)
分享论文
